Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Axsome Thera (AXSM)

Axsome Thera (AXSM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,549,484
  • Shares Outstanding, K 37,682
  • Annual Sales, $ 0 K
  • Annual Income, $ -102,900 K
  • 60-Month Beta 2.23
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 21.09
Trade AXSM with:

Options Overview Details

View History
  • Implied Volatility 145.88%
  • Historical Volatility 79.04%
  • IV Percentile 94%
  • IV Rank 89.28%
  • IV High 157.15% on 10/13/21
  • IV Low 52.08% on 01/20/21
  • Put/Call Vol Ratio 0.73
  • Today's Volume 1,916
  • Volume Avg (30-Day) 3,155
  • Put/Call OI Ratio 0.19
  • Today's Open Interest 31,994
  • Open Int (30-Day) 39,089

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.94
  • Number of Estimates 7
  • High Estimate -0.89
  • Low Estimate -1.06
  • Prior Year -0.58
  • Growth Rate Est. (year over year) -62.07%

Price Performance

See More
Period Period Low Period High Performance
1-Month
28.52 +40.88%
on 09/20/21
42.83 -6.19%
on 10/13/21
+10.46 (+35.20%)
since 09/17/21
3-Month
19.38 +107.33%
on 08/19/21
58.21 -30.97%
on 07/22/21
-15.91 (-28.37%)
since 07/19/21
52-Week
19.38 +107.33%
on 08/19/21
87.24 -53.94%
on 12/22/20
-31.87 (-44.23%)
since 10/19/20

Most Recent Stories

More News
Axsome Therapeutics Expands Term Loan Facility with Hercules Capital to $300 Million

$100 million now available upon the potential FDA approval of AXS-05 NEW YORK, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:...

AXSM : 40.18 (-2.29%)
Pre-Market Brief: U.S. Stocks Set to Open Higher as Inflation Concerns Ease

Morning Markets Dec S&P 500 futures this morning shook off overnight losses and are up +0.41. Stock index futures pushed higher this morning after U.S. Aug consumer prices rose less than expected, easing...

KERN : 3.09 (+7.29%)
ORCL : 97.06 (+0.57%)
ANGI : 12.55 (+0.97%)
MP : 35.16 (+3.23%)
OPEN : 24.02 (-0.58%)
JCS : 4.39 (-14.26%)
FIGS : 36.89 (+2.42%)
AXSM : 40.18 (-2.29%)
Tesla, Big Lots rise; Embraer, Regeneron fall

NEW YORK (AP) — Stocks that moved heavily or traded substantially on Monday:

MRO : 16.39 (-0.24%)
BIG : 46.33 (+0.76%)
REGN : 552.11 (+1.59%)
CHKP : 121.78 (+1.06%)
AXSM : 40.18 (-2.29%)
TSLA : 864.27 (-0.67%)
ERJ : 17.76 (-4.72%)
Maxar, Lending Tree rise; iHeartMedia, Lam Research fall

NEW YORK (AP) — Stocks that moved substantially or traded heavily on Monday:

LRCX : 570.83 (+0.37%)
AXSM : 40.18 (-2.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Axsome Therapeutics, Inc. is a biopharmaceutical company. The company is focused on developing novel therapies for the management of pain and other central nervous system disorders. Its product candidate portfolio consists of AXS-02 and AXS-05 which are in clinical trial stage. Axsome Therapeutics, Inc....

See More

Key Turning Points

3rd Resistance Point 43.51
2nd Resistance Point 42.70
1st Resistance Point 41.44
Last Price 40.18
1st Support Level 39.37
2nd Support Level 38.56
3rd Support Level 37.30

See More

52-Week High 87.24
Fibonacci 61.8% 61.32
Fibonacci 50% 53.31
Fibonacci 38.2% 45.30
Last Price 40.18
52-Week Low 19.38

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar